Skip to main content

Table 4 Socio-demographic and clinical factors associated with multiple adverse events

From: Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy

Characteristic at baselineCase/nCrude modelAdjusted model
OR(95%CI)POR(95%CI)P
Age, years
  < 50364/4281 2.54(0.76–8.51)0.130
  ≥ 5043/462.52(0.76–8.37)0.1311 
Marital status
 Single/divorced/widowed314/3670.89(0.47–1.68)0.723  
 Married/common law marriage93/1071   
Years of Education
  ≤ 975/880.94(0.49–1.81)0.849  
  > 9332/3861   
BMI, kg/m2
  < 24292/3511 1 
  ≥ 24115/1232.91(1.35–6.27)0.0072.72(1.25–5.89)0.012
CD4+, cells/mm3
  ≤ 199102/1201   
 200–349119/1450.81(0.421.56)0.524  
 350–499110/1241.39(0.66–2.93)0.392  
  ≥ 50076/851.49(0.64–3.50)0.360  
Viral load, cells/ml
  < 100,000327/3821   
  ≥ 100,00080/921.12(0.57–2.19)0.738  
Syphilis Status
 Yes129/1491.09(0.62–1.92)0.763  
 No278/3251   
Hepatitis Status
Positive25/310.67(0.26–1.69)0.391  
Negative382/4431   
WHO Clinical Stage
 I + II374/4331   
 III + IV33/410.65(0.29–1.48)0.651  
Pre-existing AE
 Yes346/4031.00(0.48–2.06)0.989  
 No61/711   
Pre-existing multiple AE
 Yes150/1671.72(0.96–3.08)0.0711.57(0.86–2.84)0.139
 No257/3071 1 
Pre-existing severe AE
 Yes33/361.88(0.56–6.32)0.306  
 No374/4381